Vivo Capital, LLC Geron Corp Transaction History
Vivo Capital, LLC
- $677 Million
- Q2 2024
A detailed history of Vivo Capital, LLC transactions in Geron Corp stock. As of the latest transaction made, Vivo Capital, LLC holds 27,225,292 shares of GERN stock, worth $124 Million. This represents 17.06% of its overall portfolio holdings.
Number of Shares
27,225,292
Previous 27,225,292
-0.0%
Holding current value
$124 Million
Previous $89.8 Million
28.49%
% of portfolio
17.06%
Previous 12.02%
Shares
5 transactions
Others Institutions Holding GERN
# of Institutions
258Shares Held
448MCall Options Held
1.91MPut Options Held
897K-
Black Rock Inc. New York, NY46.6MShares$213 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA46.2MShares$211 Million2.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA31.9MShares$146 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y923.9MShares$109 Million12.26% of portfolio
-
State Street Corp Boston, MA22.5MShares$103 Million0.0% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.73B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...